. The nature of the SN-peptide receptor(s) was probed with neutralizing anti-integrin monoclonal antibodies (MAb), cells lacking integrin subunits, soluble heparin, and SN-peptide columns. Cell adhesion and spreading studies confirmed the specificity of SN-peptide and revealed adhesion to be unaffected by inclusion of anti-pi-, anti-cxZe6-or anti-a&-integrin
MAb. Cells lacking PI-or cx6-integrin subunits were fully adherent.
Adhesion was heparin, but not chondroitin sulfate or heparinase, sensitive, much as is cx-dystroglycan-laminin-1 binding. Heparin eluted -155 and 180-kDa cell-surface proteins from SN-peptide columns. An additional -9l-kDa protein was eluted by EDTA. All were unrecognized by anti-Pi-integrin MAb. SN-peptide therefore interacts with three cell-surface proteins for which the identity remains to be determined.
lung; alveolar; cell adhesion; integrin; dystroglycan CELLULAR ADHESION to basement membranes is a fundamental function of many living cells for which a number of diverse ligands and receptors have been identified (12, 20) . Prominent not only in embryogenesis, such interactions play a key role in the numerous homeostatic events that mark the daily life cycle of adult epithelia, endothelia, muscle, nerve, hemopoietic, and lymphoblastic cells. The basement membrane glycoprotein laminin-1 (2) has proven to be a particularly potent source of cell adhesion activity, a function coincident with its intimate association with the basal cell surface where it is found polymerized with collagen IV, perlecan, growth factors, and possibly other components.
Elucidation of how cells interact with laminin-1 has been initiated by proteolytic fragmentation (8). As a result, it is known that the 250-kDa elastase fragment E8, which is the most adhesive domain of laminin-1, is the specific ligand of cx& (24, 25>-, (x& (16) -, and c& (15)-integrins, as well as cell surface pi 4-galactosyltransferase, which interacts with E8 oligbsaccharides during cell motility and spreading (23). Subfragmentation of E8 (8) and use of an anti-recombinant G domain antibody (32) has identified an important as-dependent cell adhesion site somewhere within the first three loops of the G domain, which is conformationally dependent and/or requires a second site in the rod domain for full activity (8). Receiving increasing attention is the -156-kDa cell-surface protein a-dystroglycan (5), for which interaction with laminin-1 or laminin-2 is heparin and EDTAinhibitable and thought to occur through oligosaccharides (5) on the last two loops of the G domain, known as the E3 region, although interaction with E8 has also been demonstrated (11).
In a screen for basement membrane molecules required for lung alveolar formation, we discovered a novel 20-amino acid cell adhesion site (SN-peptide; @l-chain amino acids 2179-2198; see Ref. 19) Afinity chromatography of receptor: SN-peptide was coupled at 1 mg/ml gel to SulfoLink (Pierce, Rockford, IL) through an added COOH-terminal cysteine according to the manufacturer's suggestions. As a control, BSA was reduced with 2-mercaptoethylamine, separated on a Sephadex G-25 column, and coupled with SulfoLink at 4.5 mg/ml gel. Coupling efficiencies were 90-95%. Cells were biotinylated according to the method of Stephens et al. (27) . Briefly, confluent cells (six 150-mm plates) were washed two times with PBS, treated with 50 ug/ml NHS-LC biotin (Pierce) in PBS for 90 min on ice, detached, and washed two times in PBS containing 50 mM glycine. Pellets were resuspended in lysis buffer containing 200 mM octyl-P-D-glucopyranoside (Sigma), 50 mM tris(hydroxymethyl)aminomethane (Tris), 100 mM NaCl, 5 mM MnC12, 2 mM phenylmethylsulfonyl fluoride (PMSF), 21 uM leupeptin, 6 uM pepstatin A, and 2 uM aprotinin (pH 7.4). Lysates were centrifuged, and supernatants were passed over a blank SulfoLink precolumn before incubation for 6 h to overnight (4°C) with paired columns of immobilized SNpeptide or BSA. Unbound material was removed by washing with 20 column volumes of running buffer (50 mM Tris, 50 mM octyl-P-D-glucopyranoside, loo-150 mM NaCl, 5 mM MnC12, and 2 mM PMSF, pH 7.4). Bound material was eluted with running buffer containing 1 ug/ml of heparin, 10 mM EDTA in place of MnC12, or both 1 ug/ml of heparin and 10 mM EDTA. Finally, a wash with 1 M NaCl in running buffer was performed.
Control columns were run in parallel using the same reagents. 
RESULTS
Adhesion to SN-peptide is dose dependent. The SNpeptide site (amino acids 2179-2198 of laminin-1 alchain; arrow on Fig. 1 ) was originally identified in a screen for a basement membrane activity(s) required for in vitro lung alveolar formation. Functional dissection revealed the activity to be mainly attributable to laminin-1 in a fragment E8 and subsequently anti-SNpeptide or SN-peptide inhibitable fashion. When presented as a 35 uM coated substrate SN-peptide supported type II alveolar and HT-1080 fibrosarcoma cell adhesion, an interaction that was EDTA inhibitable (19). As a fir s s t t ep in characterizing the relative role of SN-peptide in laminin-l-dependent cell adhesion and the nature of the cell receptor, comparative adhesion experiments were carried out with a number of different cell lines (Fig. 2) . HT-1080 fibrosarcoma (Fig. 2, A and B), Clone 10 melanoma, and NIH/3T3 embryonic cells (Fig. 2B ) all adhered particularly well in a strong dose-dependent manner ( Fig. 2A , shown for HT-1080). Adhesion by M2 melanoma, RKO rectal carcinoma, Clone A colon carcinoma, OVCAR-3 ovarian carcinoma, and JAR choriocarcinoma was moderate (Fig. 2, B and C). Less adhesive were F9 teratocarcinoma (Fig. 2B ) and PC-12 pheochromocytoma (Fig. 2, A and B) cells, with Saos-2 osteogenic sarcoma cells showing little or no affinity (Fig. 2C) . In all cases, plateau adhesion was similar to that obtainable with fragment E8, but significantly higher micromolar amounts of SN-peptide were To determine whether these latter differences were in part because of differential substrate adsorption, we included trace amounts of iodinated SN-peptide or fragment E8, revealing adsorption to be approximately threefold less for SN-peptide (Table 1) . Correcting half-maximal coating values for substrate actually adsorbed suggested an 80-fold difference in adhesion activity between SN-peptide and E8, a value pointing to a requirement for additional sites and/or E8 folding.
SN-peptide could simply represent a highly charged region of E8 that interacts in a nonselective way with a negatively charged cell surface for which the strength might vary among cell types. To examine charge and specificity, several approaches have been used. Charge was analyzed via Isoelectric (Genetics Computer Group) revealing SN-peptide to have a relatively low net charge of +2.5 at pH 7.4 ( Fig. 2A, inset) . Second, a L497 (Fig. 3) . Control antibody ab[IKl directed to al-chain amino acids 2097-2108 in the rod domain of E8 had no effect (Fig. 3 ). Taken together with previous specificity studies (191, these data are in keeping with SN-peptide representing a highly selective adhesion site.
SN-peptide specificity further revealed by selective inhibition of cell spreading. We next asked whether the SN-peptide site has a role in laminin-l-dependent cell spreading.
HT-1080 cells were plated on SN-peptide alone or on laminin-1 in the absence or presence of soluble SN-peptide (Fig. 4) . Examination 1 h later revealed no apparent spreading on SN-peptide ( Fig.  4A) , although small projections could be occasionally distinguished on careful examination (Fig. 4A, inset) . In contrast, cells rapidly spread on laminin-1 (Fig. 4B,  inset a) tion of cells with 10 pM SN-peptide (Fig. 4B, inset b) . This inhibitory effect was manifested by a leftward shift in the area distribution of individually measured cells to a curve appropriate for a round or near-round phenotype (Fig. 4B) . Decreasing the concentration of inhibitory SN-peptide lo-fold shifted the curve to an intermediate position between round and spread pheno-L498 SN-PEPTIDE RECEPTOR types (not shown). The same experiment was performed using plates coated with collagen I, fragment El' (similar to Pl) or fragment E8 (Figs. 5 and 6 ). HT-1080 spreading on collagen I was unaffected by soluble SN-peptide (10 pM; Fig. 5 , compare insets a and b). SN-peptide similarly had no apparent effect on the small amount of spreading observed on El' (Fig. 6A,  compare insets a and b) . However, E8-dependent spreading was suppressed (Fig. 6B, compare insets a and b) .
Search for the SN-peptide receptor argues against ,BI-integrins.
With both adhesion and spreading studies supporting the specificity of SN-peptide, we next turned to our main goal of identifying the SN-peptide receptor. HT-1080 cell adhesion to E8 is partially inhibitable with antibodies directed against o&i-integrin, a major laminin-1 receptor that is thought to bind E8 within the first three loops of the G domain (32). To ask whether adhesion to SN-peptide is mediated by o&i, HT-1080 cells were incubated with neutralizing anti-cxs-or antipi-antibodies (10 and 100 ug/ml) under conditions that inhibited adhesion to E8 or the similar T8 fragment (Fig. 7, inset ). Both antibodies, however, had little or no effect on adhesion to SN-peptide (Fig. 7) . Other integrins expressed by HT-1080 cells include CX&, cx&, (Y&, and possibly cq$&, but use of neutralizing anti-c+., -03, -04, -05, and -c~vl& MAb or soluble RGDS or RGES peptide at 100 pM (not shown) was also without inhibitory effect (Fig. 7) . Another E8 binding integrin, CY&, appears not to be expressed by HT-1080 cells based on lack of HT-1080 adhesion to anti-p4 MAbcoated plates (not shown 3El and UM-AS, but neither inhibited adhesion to SN-peptide (not shown).
To test these data in a different way, adhesion studies (Fig. 8) were carried out with cells lacking 06-or pl-integrin subunits. TKO and GD25 cells, in which the pi-integrin gene had been knocked out by homologous recombination (10, 27>, attached to SN-peptide (Fig.  8A ) in a dose-dependent manner (Fig. 8A , inset) at plateau levels within the range previously observed for HT-1080 cells. Both cells displayed low (TKO) or good (GD25) adhesion to laminin-1, and no specific adhesion to E8 (Fig. SA) little or no q-subunit on their surface (24), also adhered well to SN-peptide (Fig. 8 , B and C) with a similar dose-dependent relationship (Fig. 8A , inset) and showed no apparent avidity for laminin-1 (P388DJ or E8 (K-562). These results underlined the conclusion that (x&i is not the primary receptor for SN-peptide and that other q-or P1-receptors are also not likely to be directly involved. Apparently contradictory, however, was an avidity for SN-peptide in the absence of adhesion to E8, an observation made more curious by the capacity of SN-peptide to inhibit E8-dependent cell spreading.
Interaction with receptor is inhibited by heparin but not chondroitin sulfate or heparinase. Another laminin-1 receptor is a-dystroglycan, for which the interaction with laminin-1 is heparin and EDTA inhibitable but which is thought to be mediated mainly through the E3 domain (11). Cell adhesion to SN-peptide was EDTA inhibitable (19). Is it also heparin inhibitable?
HT-1080 cells were plated on SN-peptide in the presence of increasing amounts of soluble heparin revealing a dose-dependent inhibition of adhesion that was maximal at l-10 ug/ml (Fig. 9A) . Soluble chondroitin sulfate at similar levels had no effect (Fig. 9A) . Cells plated in parallel on E8 displayed no heparin inhibition of adhesion (Fig. 9A) . Parallel experiments with Clone 10 melanoma cells (Fig. 9B) revealed a similar pattern of heparin (1 ug/ml) but not chondroitin sulfate inhibition of adhesion to SN-peptide and little or no effect on adhesion to E8 (not shown). Differing somewhat were M2 melanoma cells, for which the adhesion to SNpeptide was less heparin sensitive and somewhat chondroitin sulfate sensitive (Fig. 9B) . To ask whether this response was attributable to a cell-surface heparan sulfate proteoglycan, for which a direct interaction of its glycosaminoglycan side chains with SN-peptide might be expected, we examined heparin-SN-peptide binding and whether heparinase pretreatment altered adhesion. Little or no heparin bound SN-peptide (Fig.  lo) , in contrast to laminin-1 that has a number of heparin binding sites (32). Pretreatment of HT-1080 cells with heparinase I, II, and III, at a level lo-fold higher than that which eliminated syndecan-l-dependent cell adhesion to the heparin binding domain of thrombospondin (17), however, had no effect on cell adhesion to SN-peptide (mean optical density 595 = 0.93 IT 0.05 with 1 U/ml heparinase I-III, n = 27). (Fig. 11) . For this purpose, SN-peptide columns were incubated with biotinylated HT-1080 cell surface extracts in the presence of Mn2+, octylglucoside, proteolytic inhibitors, and loo-150 mM NaCl, and then washed extensively. Subsequent addition of 1 ug/ml heparin in octylglucoside column buffer eluted a prominent -155kDa band and a lighter -180-kDa band (Fig. 11B) . A parallel BSA column was blank ( In controls, gold in the absence of heparin was added followed by silver enhancement. Inset: example mOD vs. time plot. Steepest slope through 5-7 data points was used to calculate V max. Each value in main figure represents the mean of 9 independent measurements.
-80 .
-60 .
-40 -20 -0 1lA). A similar pattern plus an -91-kDa band was apparent when SN-peptide columns were eluted with heparin (1 ug/ml) in the presence of 10 mM EDTA (Fig.  1lC ) or with EDTA alone (Fig. llD> . Immunoprecipitation of the heparin eluate with anti-pi-antibody ( Fig.  11E ) yielded little or no receptor, in contrast to the abundant amount of P1-integrin in the unbound fraction (Fig. 11E ).
DISCUSSION
The goal of the present study was to identify the receptor for amino acids 2179-2198 (SN-peptide) of the laminin al-chain, an evolutionarily conserved site required for lung alveolar formation in vitro (19). Cell adhesion studies pointed to a heparin-sensitive and PI-, p4-, or avP5-integrin-independent interaction involved in laminin-l-dependent cell spreading, which appears to be mediated mainly by cell-surface proteins of -155, -180, and -91 kDa.
Various reagents were used to assess the specificity of SN-peptide-cell interactions. Antibodies against SNpeptide inhibited cell adhesion to SN-peptide and to the 250-kDa E8 fragment that contains the SN-peptide site but not to the PI fragment derived from the crossregion of laminin-1. Soluble SN-peptide suppressed spreading by cells adherent to laminin-1 and E8 but did not affect cell spreading on the Pl-like fragment El' or on collagen I. Some, but not all, cell lines tested adhered to SN-peptide. Finally, SN-peptide columns in physiological salt selectively purified three cell-surface proteins among hundreds in the starting sample.
These results are in keeping with known interactions between cells and E8 subfragments (8, 28, 32) that had previously suggested the presence of a cell adhesion site(s) within the first three G domain loops (8). Thus E8 subfragment T8'-A, consisting of the first three loops, has cell adhesion activity, and antibodies against it (anti-rG70) inhibit HT-1080 adhesion to fragment E8 (32), a result more precisely defined by ab [SN] confirmed the SN-peptide site (designated AG-10) and revealed it to be the only linear adhesive site in the first loop (22). Two and one other sites were reported in the second and third loops, respectively (22). Differing was the proposed minimum active sequence of SIYITRF rather than SINNNR, a discrepancy possibly reflecting difficulties in adsorption by synthetic peptides of this short size, for which application of longer peptides, such as SN-peptide, is recommended. Taken together, it is apparent that SN-peptide is a specific and highly reproducible tool that offers a simple but powerful new approach to analysis of the laminin-cell interface. The capacity of EDTA to inhibit HT-1080 adhesion to and evidence pointing to o&i as the main laminin-1 integrin of HT-1080 cells (32) raised the possibility that c&i may serve as receptor for SNpeptide or 22) . Preliminary studies (7) supported this hypothesis. Commercial GoH3 anti-asantibody displayed a dramatic inhibitory response over a very narrow concentration range of 70-100 pg/ml, similar to the GoH3 concentration previously employed to inhibit kidney morphogenesis in vitro (9) but greater than the 0.5 pg/ml required to inhibit platelet adhesion to laminin-1 (26). The unreliability of this atypical dose-inhibition curve was later emphasized by observation of an identical inhibitory result with P388Di cells, for which the lack of cell surface (Yg had been verified by Fats analysis (24). Similar results at lo-fold higher antibody concentrations were obtained for the anti-pi MAb P4ClO. We subsequently chose the highest anti-o6 (10 pg/ml)-and anti-pi (100 pg/ml)-antibody concentrations that had no negative effect on P388Di or TKO (pi minus) cell adhesion to SN-peptide, respectively. Now anti-o6 and -pi inhibited HT-1080 adhesion to fragments E8 or T8 but not to SN-peptide. Finally, the putative receptor(s) eluted from SN-peptide columns with heparin or EDTA was not (Y&i, based on immunoprecipitation and Western blot analysis. the control BSA column. Nonspecific binding, presumably to column beads, is apparent from the 1 M NaCl wash (also seen in SN-peptide column runs carried out in 100 mM but usually not 150 mM NaCl Although linear SN-peptide does not appear to bind (Y&i, could SN-peptide presented in the native conformation achieved by intercalation of laminin crl-, pl-, and yl-COOH-termini contribute to the o&i-dependent adhesion complex? Partially suggestive of this possibility is the capacity of SN-peptide to suppress HT-1080 spreading on laminin-1 or E8, the latter of which would be expected to be an o&i-dependent process. Also suggestive is the inhibition of E8 adhesion by anti-SN-peptide antibody. On the other hand, steric hindrance because of proximity of SN-peptide and o&-binding sites is a plausible explanation, in which binding of the SN-peptide site.to a nonintegrin receptor could be viewed as helping to stabilize the moderately weak 06P1-E8 complex. The answer to this question m, 1~ be best determined by analysis of recombinant E8 following deletion or alteration of the SN-peptide site.
Combined heparin and EDTA sensitivity suggested that linear SN-peptide-dependent adhesion may involve a cell surface heparan sulfate proteoglycan or an o-dystroglycan-like molecule. The former possibility was tentatively ruled out by the inability of heparinase I-III predigestion to affect cell adhesion and by SN-
